Literature DB >> 25973951

HIF-1 Alpha Regulates the Response of Primary Sarcomas to Radiation Therapy through a Cell Autonomous Mechanism.

Minsi Zhang1, Qiong Qiu2, Zhizhong Li2, Mohit Sachdeva2, Hooney Min2, Diana M Cardona3, Thomas F DeLaney4, Tracy Han2, Yan Ma2, Lixia Luo2, Olga R Ilkayeva5, Ki Lui1, Amanda G Nichols1, Christopher B Newgard1,5, Michael B Kastan1,6, Jeffrey C Rathmell1,7, Mark W Dewhirst2,3, David G Kirsch1,2.   

Abstract

Hypoxia is a major cause of radiation resistance, which may predispose to local recurrence after radiation therapy. While hypoxia increases tumor cell survival after radiation exposure because there is less oxygen to oxidize damaged DNA, it remains unclear whether signaling pathways triggered by hypoxia contribute to radiation resistance. For example, intratumoral hypoxia can increase hypoxia inducible factor 1 alpha (HIF-1α), which may regulate pathways that contribute to radiation sensitization or radiation resistance. To clarify the role of HIF-1α in regulating tumor response to radiation, we generated a novel genetically engineered mouse model of soft tissue sarcoma with an intact or deleted HIF-1α. Deletion of HIF-1α sensitized primary sarcomas to radiation exposure in vivo. Moreover, cell lines derived from primary sarcomas lacking HIF-1α, or in which HIF-1α was knocked down, had decreased clonogenic survival in vitro, demonstrating that HIF-1α can promote radiation resistance in a cell autonomous manner. In HIF-1α-intact and -deleted sarcoma cells, radiation-induced reactive oxygen species, DNA damage repair and activation of autophagy were similar. However, sarcoma cells lacking HIF-1α had impaired mitochondrial biogenesis and metabolic response after irradiation, which might contribute to radiation resistance. These results show that HIF-1α promotes radiation resistance in a cell autonomous manner.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25973951      PMCID: PMC4800000          DOI: 10.1667/RR14016.1

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  49 in total

1.  The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy.

Authors:  L H GRAY; A D CONGER; M EBERT; S HORNSEY; O C SCOTT
Journal:  Br J Radiol       Date:  1953-12       Impact factor: 3.039

2.  Prognostic significance of [18F]-misonidazole positron emission tomography-detected tumor hypoxia in patients with advanced head and neck cancer randomly assigned to chemoradiation with or without tirapazamine: a substudy of Trans-Tasman Radiation Oncology Group Study 98.02.

Authors:  Danny Rischin; Rodney J Hicks; Richard Fisher; David Binns; June Corry; Sandro Porceddu; Lester J Peters
Journal:  J Clin Oncol       Date:  2006-05-01       Impact factor: 44.544

3.  Pleiotropic effects of HIF-1 blockade on tumor radiosensitivity.

Authors:  Benjamin J Moeller; Matthew R Dreher; Zahid N Rabbani; Thies Schroeder; Yiting Cao; Chuan Y Li; Mark W Dewhirst
Journal:  Cancer Cell       Date:  2005-08       Impact factor: 31.743

4.  Tumor cells upregulate normoxic HIF-1α in response to doxorubicin.

Authors:  Yiting Cao; Joseph M Eble; Ejung Moon; Hong Yuan; Douglas H Weitzel; Chelsea D Landon; Charleen Yu-Chih Nien; Gabi Hanna; Jeremy N Rich; James M Provenzale; Mark W Dewhirst
Journal:  Cancer Res       Date:  2013-08-19       Impact factor: 12.701

5.  Induction of medulloblastomas in p53-null mutant mice by somatic inactivation of Rb in the external granular layer cells of the cerebellum.

Authors:  S Marino; M Vooijs; H van Der Gulden; J Jonkers; A Berns
Journal:  Genes Dev       Date:  2000-04-15       Impact factor: 11.361

6.  Hypoxia-inducible factor-1alpha is a positive factor in solid tumor growth.

Authors:  H E Ryan; M Poloni; W McNulty; D Elson; M Gassmann; J M Arbeit; R S Johnson
Journal:  Cancer Res       Date:  2000-08-01       Impact factor: 12.701

7.  Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma.

Authors:  D M Brizel; S P Scully; J M Harrelson; L J Layfield; J M Bean; L R Prosnitz; M W Dewhirst
Journal:  Cancer Res       Date:  1996-03-01       Impact factor: 12.701

8.  The histological structure of some human lung cancers and the possible implications for radiotherapy.

Authors:  R H THOMLINSON; L H GRAY
Journal:  Br J Cancer       Date:  1955-12       Impact factor: 7.640

9.  FURTHER OBSERVATIONS ON RADIOCURABILITY OF A SOLID EHRLICH AND TISSUE REACTIONS IN THE MOUSE WITH FRACTIONATED RADIATION DOSES AND THE EFFECTS OF OXYGEN.

Authors:  H A VANDENBRENK; K ELLIOTT; H HUTCHINGS
Journal:  Br J Cancer       Date:  1963-06       Impact factor: 7.640

10.  Effect of high pressure oxygen on radiosensitivity of Ehrlich's tumour in mice after "immunological approximation".

Authors:  H A VAN DEN BRENK
Journal:  Br J Cancer       Date:  1961-03       Impact factor: 7.640

View more
  22 in total

1.  Hedgehog Pathway Drives Fusion-Negative Rhabdomyosarcoma Initiated From Non-myogenic Endothelial Progenitors.

Authors:  Catherine J Drummond; Jason A Hanna; Matthew R Garcia; Daniel J Devine; Alana J Heyrana; David Finkelstein; Jerold E Rehg; Mark E Hatley
Journal:  Cancer Cell       Date:  2018-01-08       Impact factor: 31.743

2.  Transarterial embolization combined with RNA interference targeting hypoxia-inducible factor-1α for hepatocellular carcinoma: a preliminary study of rat model.

Authors:  Jia-Yan Ni; Lin-Feng Xu; Wei-Dong Wang; Qiao-Sheng Huang; Hong-Liang Sun; Yao-Ting Chen
Journal:  J Cancer Res Clin Oncol       Date:  2016-09-16       Impact factor: 4.553

Review 3.  Inside the hypoxic tumour: reprogramming of the DDR and radioresistance.

Authors:  Katheryn Begg; Mahvash Tavassoli
Journal:  Cell Death Discov       Date:  2020-08-18

4.  Genetically engineered mouse models for studying radiation biology.

Authors:  Katherine D Castle; Mark Chen; Amy J Wisdom; David G Kirsch
Journal:  Transl Cancer Res       Date:  2017-07       Impact factor: 1.241

5.  The Future of Radiobiology.

Authors:  David G Kirsch; Max Diehn; Aparna H Kesarwala; Amit Maity; Meredith A Morgan; Julie K Schwarz; Robert Bristow; Sandra Demaria; Iris Eke; Robert J Griffin; Daphne Haas-Kogan; Geoff S Higgins; Alec C Kimmelman; Randall J Kimple; Isabelle M Lombaert; Li Ma; Brian Marples; Frank Pajonk; Catherine C Park; Dörthe Schaue; Phuoc T Tran; Eric J Bernhard
Journal:  J Natl Cancer Inst       Date:  2018-04-01       Impact factor: 13.506

6.  Hypoxia inducible factor-1α/B-cell lymphoma 2 signaling impacts radiosensitivity of H1299 non-small cell lung cancer cells in a normoxic environment.

Authors:  Gang Wang; Liang Xiao; Fen Wang; Jing Yang; Li Yang; Ye Zhao; Wensen Jin
Journal:  Radiat Environ Biophys       Date:  2019-06-15       Impact factor: 1.925

Review 7.  Molecular Predictors of Radiotherapy Response in Sarcoma.

Authors:  Carlos H F Chan; Philip Wong
Journal:  Curr Treat Options Oncol       Date:  2016-01

8.  Disturbance in the regulation of miR 17-92 cluster on HIF-1-α expression contributes to clinically relevant radioresistant cells: an in vitro study.

Authors:  Mehryar Habibi Roudkenar; Motoi Fukumoto; Amaneh Mohammadi Roushandeh; Youshikazu Kuwahra; Yusuke Uroshihara; Hiroshi Harada; Manabu Fukumoto
Journal:  Cytotechnology       Date:  2020-01-08       Impact factor: 2.058

9.  Quantitative Analysis of the Physiological Contributions of Glucose to the TCA Cycle.

Authors:  Shiyu Liu; Ziwei Dai; Daniel E Cooper; David G Kirsch; Jason W Locasale
Journal:  Cell Metab       Date:  2020-09-21       Impact factor: 27.287

10.  Acetate Production from Glucose and Coupling to Mitochondrial Metabolism in Mammals.

Authors:  Xiaojing Liu; Daniel E Cooper; Ahmad A Cluntun; Marc O Warmoes; Steven Zhao; Michael A Reid; Juan Liu; Peder J Lund; Mariana Lopes; Benjamin A Garcia; Kathryn E Wellen; David G Kirsch; Jason W Locasale
Journal:  Cell       Date:  2018-09-20       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.